Şeyda Karabörk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Şeyda Karabörk has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Sule Aydin Turkoglu
Department of Neurology, Faculty of Medicine, Bolu Abant İzzet Baysal University, Bolu, Türkiye
7 shared publications - Firdevs Uluc
Department of Interdisciplinary Neuroscience, Institute of Health Sciences, Bolu Abant İzzet Baysal University, Bolu, Türkiye
4 shared publications - Hümeyra Çelik
Alanya Alaaddin Keykubat Üniversitesi
4 shared publications - Bihter Gokce Celik
Institute of Health Sciences, Department of Interdisciplinary Neuroscience, Bolu Abant İzzet Baysal University, Bolu, Türkiye
3 shared publications Erol Ayaz
Department of Medical Parasitology, Bolu Abant İzzet Baysal University, Faculty of Medicine, Bolu, Türkiye
3 shared publications- Gamze Doğdu
BOLU ABANT İZZET BAYSAL ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ
3 shared publications
Latest Publications
- 30 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 212
Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 — a pilot study
- 30 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 212
Sexual dysfunction in multiple sclerosis: the role of orexin-A and calpain-2 — a pilot study
- Open Access
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 269-280
Investigation of some cytokine levels (IL-4, IL-5, IL-8, IL-12, and IL-33) in the sera of patients with cystic echinococcosis and fasciolosis
Aim: To evaluate serum levels of IL-4, IL-5, IL-8, IL-12p70, and IL-33 in patients with cystic echinococcosis and fascioliasis and to assess their diagnostic potential compared to healthy controls. Method: A total of 78 serum samples were analyzed, including 26 from patients with cystic echinococcosis, 26 from patients with fascioliasis, and 26 from healthy controls. Cytokine levels were measured using a multiplex ELISA assay, and intergroup comparisons were evaluated using IBM SPSS Statistics. Results: The echinococcosis group had significantly higher serum levels of IL-4, IL-5, IL-8, and IL-33 than the control group (p<0.05). Similarly, the fascioliasis group had significantly higher levels of IL-4, IL-5, and IL-8 than the control group (p<0.05), but no significant differences were observed for IL-33 and IL-12p70. Between the helminth groups, the echinococcosis group had significantly higher levels of IL-4 (p=0.003), IL-5 (p<0.001), and IL-33 (p=0.015) than the fascioliasis group. Conclusions: Cytokine profiles in helminth infections differ significantly from those in healthy controls and between parasite species. Th2-skewed responses, characterized by elevated IL-4 and IL-5 levels, were common, while IL-8 and IL-33 involvement suggests roles for both innate and adaptive immunity in disease pathogenesis. In echinococcosis, IL-33 may serve as a biomarker for early diagnosis, recurrence detection, and therapy monitoring, and it provides insights into the immune response to infections.
- 15 September 2025
- Published by Experimental Biomedical Research in Experimental Biomedical Research
- Vol. 8 (4) , 269-280
Open AccessInvestigation of some cytokine levels (IL-4, IL-5, IL-8, IL-12, and IL-33) in the sera of patients with cystic echinococcosis and fasciolosis
Aim: To evaluate serum levels of IL-4, IL-5, IL-8, IL-12p70, and IL-33 in patients with cystic echinococcosis and fascioliasis and to assess their diagnostic potential compared to healthy controls. Method: A total of 78 serum samples were analyzed, including 26 from patients with cystic echinococcosis, 26 from patients with fascioliasis, and 26 from healthy controls. Cytokine levels were measured using a multiplex ELISA assay, and intergroup comparisons were evaluated using IBM SPSS Statistics. Results: The echinococcosis group had significantly higher serum levels of IL-4, IL-5, IL-8, and IL-33 than the control group (p<0.05). Similarly, the fascioliasis group had significantly higher levels of IL-4, IL-5, and IL-8 than the control group (p<0.05), but no significant differences were observed for IL-33 and IL-12p70. Between the helminth groups, the echinococcosis group had significantly higher levels of IL-4 (p=0.003), IL-5 (p<0.001), and IL-33 (p=0.015) than the fascioliasis group. Conclusions: Cytokine profiles in helminth infections differ significantly from those in healthy controls and between parasite species. Th2-skewed responses, characterized by elevated IL-4 and IL-5 levels, were common, while IL-8 and IL-33 involvement suggests roles for both innate and adaptive immunity in disease pathogenesis. In echinococcosis, IL-33 may serve as a biomarker for early diagnosis, recurrence detection, and therapy monitoring, and it provides insights into the immune response to infections.
- 9 September 2025
- Published by Taylor & Francis in International Journal of Phytoremediation
- Vol. 28 (1) , 123-138
Characterization, photocatalysis, antimicrobial and antioxidant activities of manganese oxide nanoparticles green synthesis using Triticum monococcum seed extract
This study presents an eco-friendly approach for the green synthesis of manganese oxide nanoparticles (MnONPs) using Triticum monococcum (T. monococcum) (einkorn wheat) seed extract as a reducing and stabilizing agent. The synthesized MnONPs were characterized by UV-Vis, XRD, FTIR, SEM-EDX, BET, and zeta potential analyses, which confirmed their crystalline nature, spherical morphology, and mesoporous structure with a surface area of 41.50 m2/g. Photocatalytic experiments showed significant degradation of Rhodamine B dye, with an efficiency of 98.50% under UV light and the synergistic influence of H2O2. The antimicrobial activity of MnONPs was used through the disk diffusion method to observe the sensitivity of Gram-positive and Gram-negative bacterial strains and MnONPs inhibited the growth of Escherichia coli, and Staphylococcus aureus (MRSA and MSSA) bacteria. Antioxidant evaluations showed that MnONPs exhibited improved total oxidant and antioxidant status compared to T. monococcum extract, suggesting superior mitigation of oxidative stress. These results indicate that MnONPs synthesized via this green method are promising materials for environmental remediation and biomedical applications, particularly in oxidative stress management.
- 9 September 2025
- Published by Taylor & Francis in International Journal of Phytoremediation
- Vol. 28 (1) , 123-138
Characterization, photocatalysis, antimicrobial and antioxidant activities of manganese oxide nanoparticles green synthesis using Triticum monococcum seed extract
This study presents an eco-friendly approach for the green synthesis of manganese oxide nanoparticles (MnONPs) using Triticum monococcum (T. monococcum) (einkorn wheat) seed extract as a reducing and stabilizing agent. The synthesized MnONPs were characterized by UV-Vis, XRD, FTIR, SEM-EDX, BET, and zeta potential analyses, which confirmed their crystalline nature, spherical morphology, and mesoporous structure with a surface area of 41.50 m2/g. Photocatalytic experiments showed significant degradation of Rhodamine B dye, with an efficiency of 98.50% under UV light and the synergistic influence of H2O2. The antimicrobial activity of MnONPs was used through the disk diffusion method to observe the sensitivity of Gram-positive and Gram-negative bacterial strains and MnONPs inhibited the growth of Escherichia coli, and Staphylococcus aureus (MRSA and MSSA) bacteria. Antioxidant evaluations showed that MnONPs exhibited improved total oxidant and antioxidant status compared to T. monococcum extract, suggesting superior mitigation of oxidative stress. These results indicate that MnONPs synthesized via this green method are promising materials for environmental remediation and biomedical applications, particularly in oxidative stress management.
- 24 August 2025
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis
Identification of the related signalling pathways is very crucial for demyelinating diseases. The aim of this study was to investigate the relation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway in patients with Multiple Sclerosis (pwMS) and Neuromyelitis Optica Spectrum Disorder (pwNMOSD). We recruited 45 newly diagnosed patients during the relapse period, comprising 36 pwMS and 9 pwNMOSD. Twenty-eight patients with pseudotumor cerebri (pwPTC) were recruited as control. CAPN1, CAPN2, HMGB1, soluble TLR4 (sTLR4), NF-κB levels were compared between the groups by ELISA technique. pwMS had higher levels of CAPN1 than those with pwNMOSD and pwPTC. Similarly, pw MS had a considerably greater level of CAPN2 than pwPTC and pwNMOSD. Between the groups, there were no variations in HMGB1, sTLR4, NF-κB, and IL-37 levels. The CAPN1 and CAPN2 levels in the pwMS showed a favorable correlation. In pwMS, CAPN1 and HMGB1 also showed a positive correlation. This study proposes a valuable and novel perspective on the pathophysiology of MS, placing CAPN1 as a potentially important contributor to neuroinflammatory signalling via HMGB1. Future research should aim to validate these findings using larger, balanced cohorts and include longitudinal CSF and serum analysis. Experimental in vitro or in vivo studies investigating CAPN1 inhibition and its impact on HMGB1-related signalling are necessary to explore therapeutic implications.
- 24 August 2025
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Calpain-1, not Calpain-2, has relationship with HMGB1/TLR4/NF-ΚB signalling pathway variables in multiple sclerosis
Identification of the related signalling pathways is very crucial for demyelinating diseases. The aim of this study was to investigate the relation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway in patients with Multiple Sclerosis (pwMS) and Neuromyelitis Optica Spectrum Disorder (pwNMOSD). We recruited 45 newly diagnosed patients during the relapse period, comprising 36 pwMS and 9 pwNMOSD. Twenty-eight patients with pseudotumor cerebri (pwPTC) were recruited as control. CAPN1, CAPN2, HMGB1, soluble TLR4 (sTLR4), NF-κB levels were compared between the groups by ELISA technique. pwMS had higher levels of CAPN1 than those with pwNMOSD and pwPTC. Similarly, pw MS had a considerably greater level of CAPN2 than pwPTC and pwNMOSD. Between the groups, there were no variations in HMGB1, sTLR4, NF-κB, and IL-37 levels. The CAPN1 and CAPN2 levels in the pwMS showed a favorable correlation. In pwMS, CAPN1 and HMGB1 also showed a positive correlation. This study proposes a valuable and novel perspective on the pathophysiology of MS, placing CAPN1 as a potentially important contributor to neuroinflammatory signalling via HMGB1. Future research should aim to validate these findings using larger, balanced cohorts and include longitudinal CSF and serum analysis. Experimental in vitro or in vivo studies investigating CAPN1 inhibition and its impact on HMGB1-related signalling are necessary to explore therapeutic implications.
- Open Access
- 5 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5497
Nogo-A and NfL Levels in CSF from Newly Diagnosed Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients Positive for Anti-HHV6-A IgG Autoantibody
Background: Agents responsible for the initiation of autoimmune responses are still under investigation. The aim of this study was to determine Nogo-A and NfL levels in CSF samples from newly diagnosed multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and pseudotumour cerebri (PTC) patients positive for HHV6-A IgG autoantibody. Methods: Initial CSF samples from 42 patients were analysed by ELISA. Independent samples t tests, Mann–Whitney U tests, crosstabulation with Fisher’s exact tests and Pearson/Spearman correlation analyses were used for group comparisons. Results: Anti-HHV6A IgG positivity was highest in MS, followed by NMOSD and then PTC (6.7%), but no significant difference in positivity was found among the groups (p = 0.367). No significant difference was found among the groups for NfL or Nogo-A levels (p = 0.373, p = 0.975, respectively). Anti-HHV6A negative MS cases had lower Nogo-A levels than positive cases (p = 0.046). In addition, anti-HHV6A negative PTC cases had lower Nogo-A levels than positive cases (p = 0.015). Anti-HHV6A positive MS patients had lower Nogo-A levels than the PTC positive group and this difference was very close to significant (p = 0.063). Conclusions: Anti-HHV6A positivity was found mainly in the MS group. Anti-HHV6A was found to be associated with Nogo-A levels, especially in the MS and PTC groups. Anti-HHV6A autoantibodies might play a role in the pathophysiology of MS.
- 5 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5497
Open AccessNogo-A and NfL Levels in CSF from Newly Diagnosed Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients Positive for Anti-HHV6-A IgG Autoantibody
Background: Agents responsible for the initiation of autoimmune responses are still under investigation. The aim of this study was to determine Nogo-A and NfL levels in CSF samples from newly diagnosed multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and pseudotumour cerebri (PTC) patients positive for HHV6-A IgG autoantibody. Methods: Initial CSF samples from 42 patients were analysed by ELISA. Independent samples t tests, Mann–Whitney U tests, crosstabulation with Fisher’s exact tests and Pearson/Spearman correlation analyses were used for group comparisons. Results: Anti-HHV6A IgG positivity was highest in MS, followed by NMOSD and then PTC (6.7%), but no significant difference in positivity was found among the groups (p = 0.367). No significant difference was found among the groups for NfL or Nogo-A levels (p = 0.373, p = 0.975, respectively). Anti-HHV6A negative MS cases had lower Nogo-A levels than positive cases (p = 0.046). In addition, anti-HHV6A negative PTC cases had lower Nogo-A levels than positive cases (p = 0.015). Anti-HHV6A positive MS patients had lower Nogo-A levels than the PTC positive group and this difference was very close to significant (p = 0.063). Conclusions: Anti-HHV6A positivity was found mainly in the MS group. Anti-HHV6A was found to be associated with Nogo-A levels, especially in the MS and PTC groups. Anti-HHV6A autoantibodies might play a role in the pathophysiology of MS.
- Open Access
- 10 January 2025
- Published by Wolters Kluwer Health in Journal of Vector Borne Diseases
- Vol. 62 (3) , 320-325
CXCL13 levels in cerebrospinal fluid in relapsing-remitting multiple sclerosis: The role of Borrelia in neuroinfections
Background & objectives: This study was compared the Borrelia antibodies and chemokine ligand 13 (CXCL13) levels in cerebrospinal fluid (CSF) samples from cases diagnosed with relapsing-remitting multiple sclerosis (RRMS), radiologically isolated syndrome (RIS), and pseudotumour cerebri (PTC). Methods: A total of 43 CSF samples were collected from patients diagnosed with RRMS, RIS and PTC. We prospectively investigated Borrelia IgG and IgM antibodies in the CSF samples of the cases by enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) method, and CXCL13 levels by ELISA. Data were statistically analysed using the the Spearman rank correlation test. Results: Five antigens (protein 19, 20, 21, 58, and outer surface protein C (OspC)) were positive due to confirmation of the positive samples for Borrelia antibodies by the WB method. There were no significant differences in CSF CXCL13 levels between the three groups. The CXCL13 level was found to be statistically higher in the demyelinating group compared to the PTC group (p=0.001). Interpretation & conclusion: The Borrelia antibodies were found positive in CSF samples of RRMS patients. The coexistence of high CXCL13 (may be a potential biomarker) suggests that LNB may also play a role in the etiopathogenesis of RRMS. In addition, the positive detection of OspC and p58 WB bands in most cases suggests that these protein bands can be used as in the differential diagnosis of neurodegenerative diseases and Lyme disease.
- 10 January 2025
- Published by Wolters Kluwer Health in Journal of Vector Borne Diseases
- Vol. 62 (3) , 320-325
Open AccessCXCL13 levels in cerebrospinal fluid in relapsing-remitting multiple sclerosis: The role of Borrelia in neuroinfections
Background & objectives: This study was compared the Borrelia antibodies and chemokine ligand 13 (CXCL13) levels in cerebrospinal fluid (CSF) samples from cases diagnosed with relapsing-remitting multiple sclerosis (RRMS), radiologically isolated syndrome (RIS), and pseudotumour cerebri (PTC). Methods: A total of 43 CSF samples were collected from patients diagnosed with RRMS, RIS and PTC. We prospectively investigated Borrelia IgG and IgM antibodies in the CSF samples of the cases by enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) method, and CXCL13 levels by ELISA. Data were statistically analysed using the the Spearman rank correlation test. Results: Five antigens (protein 19, 20, 21, 58, and outer surface protein C (OspC)) were positive due to confirmation of the positive samples for Borrelia antibodies by the WB method. There were no significant differences in CSF CXCL13 levels between the three groups. The CXCL13 level was found to be statistically higher in the demyelinating group compared to the PTC group (p=0.001). Interpretation & conclusion: The Borrelia antibodies were found positive in CSF samples of RRMS patients. The coexistence of high CXCL13 (may be a potential biomarker) suggests that LNB may also play a role in the etiopathogenesis of RRMS. In addition, the positive detection of OspC and p58 WB bands in most cases suggests that these protein bands can be used as in the differential diagnosis of neurodegenerative diseases and Lyme disease.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 36-42
Protective Effects of Aronia melanocarpa Extract against Cyclophosphamide-Induced Delayed Toxicity on the Bladder
Aim: Aronia melanocarpa is a red-purple medicinal fruit known for its therapeutic properties in the urinary system by anti-inflammatory effects with high antioxidant content. The aim of the study is to show the supportive effect of Aronia melanocarpa extract delayed toxicity on the bladder induced by cyclophosphamide (CYC) that an antineoplastic agent. Material and Methods: In the study three groups were constituted control (n=7), CYC(urotoxicity group, n=7) and CYC+ARONIA(treatment group, n=7). 100 mg/kg CYC intraperitoneally were given to CYC and CYC+ARONIA groups and waited for 4 weeks to be created delayed toxicity. At the end of the 4 weeks, 200 mg/kg Aronia melanocarpa was administered 15 times by oral gavage every other different day to CYC+ARONIA group (1 month in total). Sacrification was performed and after serum and urine samples were taken, the bladder was released from the sphincter region with curved-tipped forceps. Bladder tissues were investigated histologically. P38 mitogen activated preotein kinase (P38 MAPK), total antioxidant (TAS) and oxidant (TOS) status were evaluated in serum and urine samples. Results: In histology, histological damage in the bladder continued in the CYC group, while Aronia melanocarpa treatment caused healing in the bladder tissue in the CYC+ARONIA group. No difference was found between the groups in terms of P38 MAPK, TAS and TOS in serum and urine samples. Conclusion: According to the experimental results, the fact that Aronia melanocarpa extract improves the histological damage caused by CYC in the delayed period, and the serum and urine findings were the same as the controls, brought up the therapeutic effect of Aronia melanocarpa in urotoxicity.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 36-42
Protective Effects of Aronia melanocarpa Extract against Cyclophosphamide-Induced Delayed Toxicity on the Bladder
Aim: Aronia melanocarpa is a red-purple medicinal fruit known for its therapeutic properties in the urinary system by anti-inflammatory effects with high antioxidant content. The aim of the study is to show the supportive effect of Aronia melanocarpa extract delayed toxicity on the bladder induced by cyclophosphamide (CYC) that an antineoplastic agent. Material and Methods: In the study three groups were constituted control (n=7), CYC(urotoxicity group, n=7) and CYC+ARONIA(treatment group, n=7). 100 mg/kg CYC intraperitoneally were given to CYC and CYC+ARONIA groups and waited for 4 weeks to be created delayed toxicity. At the end of the 4 weeks, 200 mg/kg Aronia melanocarpa was administered 15 times by oral gavage every other different day to CYC+ARONIA group (1 month in total). Sacrification was performed and after serum and urine samples were taken, the bladder was released from the sphincter region with curved-tipped forceps. Bladder tissues were investigated histologically. P38 mitogen activated preotein kinase (P38 MAPK), total antioxidant (TAS) and oxidant (TOS) status were evaluated in serum and urine samples. Results: In histology, histological damage in the bladder continued in the CYC group, while Aronia melanocarpa treatment caused healing in the bladder tissue in the CYC+ARONIA group. No difference was found between the groups in terms of P38 MAPK, TAS and TOS in serum and urine samples. Conclusion: According to the experimental results, the fact that Aronia melanocarpa extract improves the histological damage caused by CYC in the delayed period, and the serum and urine findings were the same as the controls, brought up the therapeutic effect of Aronia melanocarpa in urotoxicity.
- Open Access
- 11 March 2024
- Published by Osmaniye Korkut Ata Universitesi in Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 7 (2) , 902-923
Effects of Microplastics on Newborn Exposure and Immune System
Mikroplastikler (MP'ler), çevre ve insan sağlığına yönelik potansiyel riskler taşıdıklarından küresel arenada hararetle tartışılan sıcak gündem konularından biridir. Hamilelik, bebeklik ve çocukluk, çevresel maruziyet için hassas pencerelerdir. Ancak nano ve mikroplastiklere (NMP'ler) maruz kalmanın sağlık üzerindeki etkileri henüz büyük ölçüde araştırılmamış veya bu konuda spesifik olarak belirlenmiş metotlarla yapılan özellikle erken yaşam maruziyeti açısından incelemelere literatürde rastlanılmamıştır. Bu derlemede amaç, MP’ler üzerinde yapılan toksikolojik araştırmaların çocuklar özellikle de yenidoğanlar üzerinde henüz yeterince odaklanılmadığı düşünülerek bu konuda literatür boşluklarını doldurmak, ilgili sektörler, karar vericiler ve toplumun her kesiminden ferdin bilinçlendirilmesini sağlamaktır. Ayrıca, bu farkındalık sayesinde, yaşamın erken dönemlerinde plastiğe maruziyetin azaltılmasına yönelik fırsatlara vesile olacak tedbirlere yönelik öneriler sunmaktır.
- 11 March 2024
- Published by Osmaniye Korkut Ata Universitesi in Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- Vol. 7 (2) , 902-923
Open AccessEffects of Microplastics on Newborn Exposure and Immune System
Mikroplastikler (MP'ler), çevre ve insan sağlığına yönelik potansiyel riskler taşıdıklarından küresel arenada hararetle tartışılan sıcak gündem konularından biridir. Hamilelik, bebeklik ve çocukluk, çevresel maruziyet için hassas pencerelerdir. Ancak nano ve mikroplastiklere (NMP'ler) maruz kalmanın sağlık üzerindeki etkileri henüz büyük ölçüde araştırılmamış veya bu konuda spesifik olarak belirlenmiş metotlarla yapılan özellikle erken yaşam maruziyeti açısından incelemelere literatürde rastlanılmamıştır. Bu derlemede amaç, MP’ler üzerinde yapılan toksikolojik araştırmaların çocuklar özellikle de yenidoğanlar üzerinde henüz yeterince odaklanılmadığı düşünülerek bu konuda literatür boşluklarını doldurmak, ilgili sektörler, karar vericiler ve toplumun her kesiminden ferdin bilinçlendirilmesini sağlamaktır. Ayrıca, bu farkındalık sayesinde, yaşamın erken dönemlerinde plastiğe maruziyetin azaltılmasına yönelik fırsatlara vesile olacak tedbirlere yönelik öneriler sunmaktır.
- Open Access
Investigation of the Relationship Between Calpain and HMGB1/TLR4/NF-KB Signalling Pathway in Multiple Sclerosis and Other Demyelinating Diseases
Background: To develop more effective treatments for demyelinating diseases, it is essential to identify the associated signaling pathways and factors. The objective of this study was to investigate the possible correlation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway and to evaluate the influence of these proteins on Interleukin 17A (IL-17A) and Interleukin 37 (IL-37) cytokines in individuals with newly diagnosed and untreated Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Methods: In this pilot study, a total of 73 newly diagnosed patients were recruited, including 36 with MS, 9 with NMOSD, and an unhealthy control group composed of 28 individuals with Pseudotumour cerebri (PTC). To ensure accuracy and transparency, all groups’ demographic and clinical characteristics were meticulously described. ELISA technique was utilized to compare levels of CAPN1, CAPN2, HMGB1, TLR4, and NF-KB, as well as IL-17A and IL-37 cytokines, between the case and the unhealthy control groups. The expectation from these findings is to provide valuable insights into the pathophysiological mechanisms of these neurological disorders, possibly opening the door to novel therapeutic perspectives. Results: In patients with MS, the levels of CAPN1 were found to be higher than those in patients with NMOSD and PTC. Similarly, the level of CAPN2 was significantly higher in patients with MS than in patients with NMOSD and higher in patients with PTC than in patients with NMOSD. There were no differences in the levels of HMGB1, TLR4, NF-κB, IL-17A, and IL-37 between the groups. Age and gender did not affect any of the parameters. In the MS group, both CAPN1 and CAPN2 showed positive correlation with HMGB1, TLR4, and NF-κB levels. Conclusions: It may be suggested that CAPN1 may exhibit greater efficacy than CAPN2 during the initial stages of neuroinflammation. To obtain deeper and more guiding results of the varying levels of CAPN1 and CAPN2, and their relationship with the HMGB1/TLR4/NF-κB signaling pathway, it is advisable to conduct in-vivo and in-vitro prospective studies featuring CAPN1-specific inhibitors with larger study groups.
Open AccessInvestigation of the Relationship Between Calpain and HMGB1/TLR4/NF-KB Signalling Pathway in Multiple Sclerosis and Other Demyelinating Diseases
Background: To develop more effective treatments for demyelinating diseases, it is essential to identify the associated signaling pathways and factors. The objective of this study was to investigate the possible correlation between Calpain-1 (CAPN1) and Calpain-2 (CAPN2) with the HMGB1/TLR4/NF-κB signaling pathway and to evaluate the influence of these proteins on Interleukin 17A (IL-17A) and Interleukin 37 (IL-37) cytokines in individuals with newly diagnosed and untreated Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Methods: In this pilot study, a total of 73 newly diagnosed patients were recruited, including 36 with MS, 9 with NMOSD, and an unhealthy control group composed of 28 individuals with Pseudotumour cerebri (PTC). To ensure accuracy and transparency, all groups’ demographic and clinical characteristics were meticulously described. ELISA technique was utilized to compare levels of CAPN1, CAPN2, HMGB1, TLR4, and NF-KB, as well as IL-17A and IL-37 cytokines, between the case and the unhealthy control groups. The expectation from these findings is to provide valuable insights into the pathophysiological mechanisms of these neurological disorders, possibly opening the door to novel therapeutic perspectives. Results: In patients with MS, the levels of CAPN1 were found to be higher than those in patients with NMOSD and PTC. Similarly, the level of CAPN2 was significantly higher in patients with MS than in patients with NMOSD and higher in patients with PTC than in patients with NMOSD. There were no differences in the levels of HMGB1, TLR4, NF-κB, IL-17A, and IL-37 between the groups. Age and gender did not affect any of the parameters. In the MS group, both CAPN1 and CAPN2 showed positive correlation with HMGB1, TLR4, and NF-κB levels. Conclusions: It may be suggested that CAPN1 may exhibit greater efficacy than CAPN2 during the initial stages of neuroinflammation. To obtain deeper and more guiding results of the varying levels of CAPN1 and CAPN2, and their relationship with the HMGB1/TLR4/NF-κB signaling pathway, it is advisable to conduct in-vivo and in-vitro prospective studies featuring CAPN1-specific inhibitors with larger study groups.
- Open Access
- 30 January 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (1) , 7-13
Does cerebrospinal fluid IL-17F distinguish normal pressure hydrocephalus from dementia?
Aim: The neurological disorder known as normal pressure hydrocephalus (NPH), which has an unknown cause, may be treatable, and is defined by a clinical triad of symptoms. A phenomenon known as dementia refers to a decline in cognitive performance that goes beyond what may be anticipated from the typical effects of biological aging. The symptomatic similarity between these two diseases causes problems in diagnosis. The objective of our study was to compare the concentrations of IL-17A, IL-17F, IL-34, and CXCL13 in the cerebrospinal fluid (CSF) of patients with NPH and dementia for an informative laboratory diagnosis. Methods: The study included NPH and dementia cases (n=7, n=5, respectively) taken from the patients’s CSF sample by lumbar puncture (LP). The levels of IL-17A, IL-17F, IL-34, and CXCL13 were measured in the CSF of patients' with NPH and dementia by enzyme-linked assay (ELISA) and compared between the two different groups. Results: There was no difference in age between the NPH and dementia groups (p=0.5). There was no statistically significant difference was found in IL-17A (p=0.7), IL-34 (p=0.9), and CXCL13 (p=0.2) in the inflammatory marker analysis in the CSF. The groups had a statistically significant difference in IL-17F (p=0.04). Conclusion: IL-17F can be an important laboratory marker used in the differential diagnosis of NPH and dementia.
- 30 January 2024
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 4 (1) , 7-13
Open AccessDoes cerebrospinal fluid IL-17F distinguish normal pressure hydrocephalus from dementia?
Aim: The neurological disorder known as normal pressure hydrocephalus (NPH), which has an unknown cause, may be treatable, and is defined by a clinical triad of symptoms. A phenomenon known as dementia refers to a decline in cognitive performance that goes beyond what may be anticipated from the typical effects of biological aging. The symptomatic similarity between these two diseases causes problems in diagnosis. The objective of our study was to compare the concentrations of IL-17A, IL-17F, IL-34, and CXCL13 in the cerebrospinal fluid (CSF) of patients with NPH and dementia for an informative laboratory diagnosis. Methods: The study included NPH and dementia cases (n=7, n=5, respectively) taken from the patients’s CSF sample by lumbar puncture (LP). The levels of IL-17A, IL-17F, IL-34, and CXCL13 were measured in the CSF of patients' with NPH and dementia by enzyme-linked assay (ELISA) and compared between the two different groups. Results: There was no difference in age between the NPH and dementia groups (p=0.5). There was no statistically significant difference was found in IL-17A (p=0.7), IL-34 (p=0.9), and CXCL13 (p=0.2) in the inflammatory marker analysis in the CSF. The groups had a statistically significant difference in IL-17F (p=0.04). Conclusion: IL-17F can be an important laboratory marker used in the differential diagnosis of NPH and dementia.